NCT00699504 - Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Healthy

Interventions

DRUG

cangrelor

IV bolus 60 mcg/kg; 8 mcg/kg x 3 hrs

DRUG

cangrelor

30 mcg/kg bolus; 4 mcg/kg/min x 3 hrs. Oral placebo capsule

DRUG

cangrelor

60 mcg/kg bolus; 8 mcg/kg/min x 3 hrs. Oral placebo capsule

DRUG

moxifloxacin

400 mg orally. Placebo IV bolus and infusion.

DRUG

placebo

placebo IV and oral

Trial Locations (1)

Charles River Clinical Services NW, Tacoma